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Abstract
Background: Many studies have addressed influenza vaccine uptake in risk-group populations (e.g. the elderly).
However, it is also necessary to assess influenza vaccine uptake in the active adult population, since they are
considered to be a high-transmitter group. In several countries pharmacists are involved in adult vaccination in
order to increase uptake. This study therefore aimed to investigate the determinants of influenza vaccination uptake
and examine the willingness to be vaccinated by pharmacists.
Methods: A cross-sectional study was conducted among Hungarian adults using a self-administered online
questionnaire distributed via social media (Facebook). The questionnaire included five domains: demographics,
vaccine uptake, factors that motivated or discouraged vaccination, knowledge and willingness of participants to
accept pharmacists as influenza vaccine administrators. Descriptive statistics were applied and logistic regression
was conducted to assess the possible determinants of vaccination uptake.
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Results: Data from 1631 participants who completed the questionnaires were analysed. Almost 58% of respondents
(944/1631) had occupational and/or health risk factors for influenza. Just over one-tenth (12.3%;200/1631) of
participants were vaccinated during the 2017/18 influenza season, 15.4% (145/944) of whom had a risk factor for
influenza. Approximately half of the participants (47.4%) believed that influenza vaccination can cause flu, and just
over half of them (51.6%), were not knowledgeable about the safety of influenza vaccine ingredients. Logistic
regression found that age, sex, health risk factor and knowledge on influenza/influenza vaccination were associated
with influenza vaccination uptake (p < 0.05). The most frequently cited reason for having an influenza vaccination
was self-protection (95.0%). The most common reason given for refusing the influenza vaccine was that the
respondent stated they rarely had an infectious disease (67.7%). The number of participants who were willing to be
vaccinated by pharmacists was two-times higher than the number of participants who were actually vaccinated
during the 2017/18 influenza season.
Conclusion: Influenza vaccine uptake in the active adult population is low in Hungary. Public awareness and
knowledge about influenza vaccination and influenza disease should be increased. The results also suggest a need
to extend the role played by pharmacists in Hungary.
Keywords: Influenza vaccine, Vaccine uptake, Determinants, Adult, Pharmacists
Background
Influenza is a highly infectious viral disease that spreads
around the world in annual outbreaks, resulting in be-
tween 3 and 5 million cases of severe illness and 290,
000–650,000 deaths [1, 2]. One study ranked influenza
as the infectious disease with the highest impact on
population health in Europe [3].
The most effective way for individuals to avoid this
disease is to have an influenza vaccination each year [1,
4]. Influenza vaccination has been recommended by the
WHO for some specific populations (e.g. pregnant
women and the elderly) [1]. Despite the well-recognised
target population for seasonal influenza vaccination,
there is some evidence suggesting that vaccination
should be also prioritised among those with the highest
number of social contacts, i.e. schoolchildren and active
adults, to avoid transmission of infections and large out-
breaks [5, 6]. Additionally, protective immune response
after vaccination may develop in higher rate in the
young ones, compared to elderly with immunosenes-
cence [7].
Factors relating to influenza vaccine uptake have pre-
viously been investigated mainly in the Western Euro-
pean countries and the USA [8, 9]; a limited number of
studies have been performed in Central and Eastern
European countries [8–10]. In a multi-site study from
eleven European countries, various factors (e.g. socio-
economics factors, gender, size of household, educa-
tional level and household income) were identified as
potential determinants of influenza vaccine uptake, but
no data was reported for Hungary [10]. Therefore, there
is a need to assess and understand factors that may in-
fluence influenza vaccination uptake in Hungary. Beside
the lack of knowledge on associated factors of influenza
uptake in Hungary, the other motivation of this research
was that no other studies focused specifically on the ac-
tive adult population, which may play crucial role in flu
epidemic development.
A review article summarised the strategies that have
been applied in an attempt to achieve higher coverage
rates for influenza vaccination [11]. As access to influenza
vaccination is an important challenge in many countries,
one of the recommended strategies was the involvement
of community pharmacists as influenza vaccine adminis-
trators, due to their better access to patients and more
convenient opening time. Pharmacy-based vaccination
services have been gradually developing since the end
of the twentieth century. These services were first
established in Argentina, South-Africa, USA and
Australia, but have since expanded to some European
countries (Denmark, Ireland, Portugal, Switzerland
and the UK) and also to some countries outside of
Europe (Canada, Philippines) [12–14]. A systematic
review and meta-analysis showed that the involvement
of pharmacists in vaccination programmes, whether as
educators, facilitators or administrators of vaccines,
resulted in increased vaccination rates [15]. Accord-
ingly, the International Federation of Pharmacists
(FIP) has a strong commitment to improve vaccin-
ation coverage through pharmacists and actively advo-
cate pharmacy vaccination for more than a decade
[14, 16]. Despite the well-recognised benefits of the
involvement of pharmacists, no pharmacy-based vac-
cination services currently exist in Central or Eastern
Europe and it is important to observe whether the
patients willing to be vaccinated by pharmacists in
Hungary. As access to influenza vaccination may be
challenging for Hungarian adults as well, there is po-
tential to improve access and vaccination uptake by
enabling pharmacists to give flu vaccinations.
Galistiani et al. BMC Public Health          (2021) 21:521 Page 2 of 13
The main objective of the present study was to investi-
gate the determinants of influenza vaccination uptake in
the active adult population in Hungary and secondly to
explore participants’ willingness to accept pharmacists as
influenza vaccine administrators.
Methods
Study design and setting
The study was an observational cross-sectional study
carried out in Hungary between March and July 2018.
The self-administered questionnaire was distributed via
social media (Facebook). Facebook is the most popular
social media used in Hungary and majority (80%) of the
users belong to the 20–59 years age group [17]. The
questionnaire was constructed on Google docs and the
link was shared to public via various Hungarian Face-
book Groups (N = 35). In order to achieve a neutral sam-
pling, we targeted participants based on various leisure
time activities (i.e. different newspaper readers, fisher-
men, bee keepers, cooking groups, etc.). First, we con-
tacted the group administrators to put the link on the
open page and sent them reminders for 2–3 times.
Participants
Everyone who lives in Hungary, understands Hungarian
and has a Facebook account was eligible to voluntarily
take part in this study. No financial or other incentives
were applied. During the analysis, however, we focused
on the active adult population, aged 20 to 59 years.
Sample size
We adopted the sample size calculation written by
Lemeshow et al. and published by the World Health Or-
ganisation [18]. We assumed that each of the main out-
come measures has a prevalence between 5 and 95%
(not very rare or very frequent). After we targeted the
highest minimal sample size (N = 384) that could be re-
quired, with a precision estimate of ±5% and the type I
error (alpha) of 5% at 95% confidence level.
Questionnaire
The survey instrument was a questionnaire. The ques-
tions included general characteristics (e.g. age, sex, risk
factors for influenza based on The Annual Vaccine
Guideline of the Hungarian Ministry of Health [19]), up-
take of the seasonal influenza vaccine during the 2017/
18 influenza season, factors motivating or discouraging
uptake of the vaccine (see complete list of questions in
Table 3), participants’ knowledge in relation to influenza
and influenza vaccination (see complete list of questions
in Table 5) and the willingness of the participants to re-
ceive an influenza vaccination from their community
pharmacist. Questions on potential determinants and
knowledge items were based on published studies [20–
23] and own ideas of the study team. The study team
discussed potential questions at several rounds, and in-
cluded questions after consensus. Then the question-
naire was piloted with a sample of ten individuals to
ensure the clarity of the questions.
Binary questions were asked about both seasonal influ-
enza vaccination uptake and the willingness of partici-
pants to receive an influenza vaccination from a
pharmacist. Multiple choice questions were used to gain
information relating to factors motivating or discour-
aging influenza vaccination uptake.
The knowledge of participants relating to influenza/in-
fluenza vaccination was measured using a set of 17 ques-
tions. For each question, there were three possible
answers: yes’, no’ or don’t know’. One point was
assigned for each correct answer, zero points were given
for the don’t know’ answer and one point was sub-
tracted for giving the wrong answer. Finally, the total
was calculated, with a range from − 17 to + 17, then cal-
culated as the percentage of the total achievable points.
For this knowledge section, the answers of participants
who had more than five missing answers were excluded
from the analysis.
Data analysis
Descriptive, bivariate and multivariate statistical analyses
were applied to describe all survey items. Descriptive
statistics, including means, standard deviations and per-
centages were used to describe all variables. Bivariate
analyses, such as Pearson’s chi-square test and Fisher’s
exact test, were used to compare categorical variables.
Logistic regression was conducted to assess the potential
associated factors of influenza vaccination uptake and
adjusted odds ratios were reported. The level of statis-
tical significance was set at p < 0.05. All statistical ana-
lyses were performed using R software (R version 3.6.1).
Results
In total, 1842 questionnaires were filled. Of these, 1631
questionnaires were analysed and 211 were excluded
since those were filled by participants who were not in
the active adult (20–59 years old) population (Fig. 1).
The mean age of participants was 33.7 years (SD = 10.7;
CI 95% 33.2–34.2), while 944 participants (57.9%; CI
95% 55.5–60.3) had occupational and/or health risk fac-
tors for influenza. Just over one-tenth (12.3%; CI 95%
10.8–13.9) of participants had received an influenza vac-
cination during the previous influenza season, and 15.4%
(145/944; CI 95% 13.2–17.8) of those had a risk factor
for influenza. The general characteristics of the partici-
pants are presented in Table 1.
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Demographics relating to vaccination uptake among
participants
Overall, there were significant differences in age, sex, educa-
tional level, occupational risk factor, health risk factor and
knowledge of vaccinated versus unvaccinated participants
(p < 0.05) in the bivariate analysis. Participants’ type of resi-
dence was the only variable that showed no significant dif-
ference between vaccinated and unvaccinated participants
(Table 1). Furthermore, logistic regression showed that age,
sex, health risk factor and knowledge about influenza were
associated with influenza vaccination uptake (Table 2).
Factors which motivated or discouraged vaccination
uptake
The reasons for obtaining or not obtaining the influenza
vaccination are summarised in Table 3. The most com-
monly cited reasons for having the vaccination were
self-protection’ (95.0%), to protect those with risk fac-
tors around’ (61.0%) and consider influenza as severe dis-
ease’ (52.5%). The most cited reasons for not having the
vaccination were I rarely get infectious diseases’ (67.7%),
followed by I do not have a risk factor’ (48.9%) and no-
body has risk factor around’ (41.0%). In total, 700 (48.9%)
unvaccinated participants selected I do not have a risk
factor’ as their reason for not having the vaccination; how-
ever, we discovered that in reality just over half of them
(353/700) had at least one risk factor for influenza.
Table 4 shows the role played by different sources of
advice or opinions when it came to participants’ vaccin-
ation status. Most participants stated that they were not
influenced (indifferent or not influenced categories) by
any external opinions with regard to their influenza vac-
cination uptake. Approximately one-third of vaccinated
participants stated that their decision had been influ-
enced by a recommendation from a specialist doctor, a
GP, another healthcare worker or a family member.
Knowledge of influenza vaccination/influenza disease
The participants’ knowledge in response to certain ques-
tions is summarised in Table 5. Most participants
(93.6%) knew that influenza is an infectious disease. On
the other hand, approximately half of the participants
(47.4%) believed that influenza vaccination can cause flu,
and just over half of them (51.6%), calculated from the
sum of ‘wrong’ and ‘unknown’ answers) were not
knowledgeable about the safety of influenza vaccine in-
gredients (Table 5).
In total, only 30.6% of all participants gave a correct
answer to the statement flu vaccine can cause influ-
enza disease’; however, the vaccinated group showed
better knowledge compared with the knowledge of the
unvaccinated group (54.5% vs 27.3%) (Table 5). More-
over, vaccinated participants scored higher for each
knowledge question in comparison with the scores of
non-vaccinated participants. This higher level of know-
ledge was identified as one of the factors associated with
influenza vaccine uptake (p < 0.05) (Table 2).
There were large differences in the level of knowledge
between vaccinated and unvaccinated participants with re-
gard to assumptions that influenza vaccination is the best
method to prevent influenza (12.5% vs 55.4%), the safety
of vaccine ingredients (19.5% vs 56.1%) and whether the
influenza vaccine can cause influenza disease (44.5% vs
71.2%) (These numbers were calculated from the sum of
‘wrong’ and ‘unknown’ answers in Table 5).
Willingness to accept pharmacists as influenza vaccine
administrators
Overall, almost one-third (29.1%; CI 95% 26.9–31.3) of
all participants would accept an influenza vaccination
from a pharmacist. Table 6 shows that the willingness to
accept pharmacists as vaccine administrators was signifi-
cantly higher among participants who had been
Fig. 1 Flow chart of participants in the study
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vaccinated during the last influenza season (p < 0.05).
Similarly, the mean knowledge score of participants who
were willing to get their influenza vaccination at a phar-
macy was significantly higher compared with the know-
ledge of those who said they would refuse a pharmacy-
based service (p < 0.05). The number of participants who
were willing to be vaccinated by pharmacists (n = 474)
was two times higher than the number of participants
who were actually vaccinated during the 2017/18 influ-
enza season (n = 200).
Discussion
There are limited data available relating to influenza vac-
cine uptake patterns in Central and Eastern Europe. The
technical report of the ECDC on seasonal influenza
Table 1 Bivariate analysis of participants’ general characteristics and influenza vaccination uptake during the 2017/18 influenza
season
Variable Vaccination status Statistical test p-
value
Yes (n = 200) No (n = 1431) Total
Number (Row %) Number (Row %) Number (Col.%)
Age (years)
(mean ± SD) 37.5 ± 11.2 33.2 ± 10.5 33.7 ± 10.7 Welch’s two Sample t-test < 0.001
Sex
Male 50 (16.1) 260 (83.9) 310 (19.0) Pearson’s Chi-square test 0.0214
Female 150 (11.4) 1170 (88.6) 1320 (80.9)
N/A 0 (00.0) 1 (100) 1 (00.0)
Type of residence
Village 33 (13.3) 225 (86.8) 258 (15.8) Pearson’s Chi-square test 0.7587
City 166 (12.1) 1205 (87.9) 1371 (84.1)



























Occupational risk factor a
Yes 88(17.2) 424(82.8) 512(31.4) Pearson’s Chi-square test < 0.001
No 112(10.1) 1002(89.9) 1114(68.3)
N/A 0(0.0) 5(100) 5(0.3)
Health risk factor b
Yes 95(15.1) 536(84.9) 631(38.7) Pearson’s Chi-square test 0.0063
No 105(10.5) 895(89.5) 1000(61.3)
Knowledge (N = 1609)
(mean ± SD) 85.4 ± 9.7 70.7 ± 15.1 72.5 ± 15.3 Welch’s two Sample t-test < 0.001
aOccupational risk factors include participants who have at least one of the following statuses: students in the health care field; work in health care services; social
institution/long care term facility; nursery school/kindergarten; livestock or animal transfer (swine, poultry, horse); poultry processing or abattoir; work with
immigrants/foreign people
bHealth risk factors include participants who had at least one of the following conditions in the previous year: heart failure; coronary artery disease; chronic
pulmonary disease; immune disease; taking immunosuppressive drugs; inflammatory bowel disease; chronic liver disease; chronic kidney disease; pregnancy/
planning pregnancy; disabled (physically); smoker
Table 2 Logistic regression analysis to identify associated
factors for influenza vaccination uptake (n = 1602)
OR 95% CI p-value
Age 1.028 1.012–1.044 0.001
Sex (male) 1.838 1.217–2.774 0.004
Occupational risk factor 1.211 0.838–1.751 0.309
Health risk factor 2.070 1.472–2.910 0.000
Educational level – Primary (reference) – – –
Secondary 0.568 0.149–2.171 0.408
Tertiary 0.585 0.153–2.241 0.434
Knowledge 1.096 1.078–1.114 0.000
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coverage rate [24] showed that in Hungary, vaccination
rate among the elderly (above 60 years) was 21.9% in
2017/2018, which is far from the target of 75%. In the
present study focusing on only active adults, the influ-
enza vaccination uptake of respondents was low, 12.3%.
A similarly low level (9.5%) of vaccination coverage was
reported from Poland (considering the whole popula-
tion), and generally influenza vaccination uptake was
suboptimal across Europe [10]. More than half (944/
1631) of participants in the present study had occupa-
tional and/or health risk factors, and only 15.4% of them
had been vaccinated against influenza. Recent studies
have reported that vaccination rates among adults aged
16 to 65 years old who had a risk factor were higher, at
between 29.8 and 49.2% in Australia and between 45.7
and 49.4% in England [25, 26].
Our findings showed that approximately one in two
participants believed that the influenza vaccine can cause
influenza (47.4%) and half of them were not
knowledgeable about the safety of influenza vaccine in-
gredients (51.6%). These factors might have influenced
these participants’ decisions not to have an influenza
vaccination during the 2017/18 influenza season.
Demographics relating to vaccination uptake among
participants
With regard to the demographic factors associated with
influenza vaccine uptake, some of our findings are similar
to previously published findings. In the present study,
older age was associated with influenza vaccination uptake
(Table 2). A similar finding was reported by a systematic
review that focused on European and Asian populations
[27]. The present study also showed that being male was
associated with being vaccinated (Table 2). Additionally,
some studies have noted that being female can be a barrier
to influenza vaccine uptake [8, 10, 28]. However, the
aforementioned systematic review reported that sex was
not a consistent predictor of influenza vaccination across
different European countries [27].
Another factor associated with influenza vaccination
uptake was having a health risk factor. A similar asso-
ciation between health risk factors and vaccine uptake
has been reported in some previous studies [20, 28,
29]. However, the earlier systematic review found that
occupational health risk factors were not a consistent
predictor of influenza vaccination uptake [27].
Table 3 Participants’ cited reasons for their vaccination statusa
Reasons for being … Number (%)
Vaccinated, n = 200 (100%)
To protect myself from the flu and its complications 190(95.0)
To protect those with risk factors around me 122(61.0)
I consider flu a severe disease 105(52.5)
I belong to a risk group, I am prone to infections/diseases 69(34.5)
I had severe influenza previously 31(15.5)
Death due to influenza complications around me (in my neighbourhood) 7(3.5)
Unvaccinated, n = 1431 (100%)
Because I rarely get infectious diseases (including influenza) 968(67.7)
Because I do not have a risk factor 700(48.9)
Because nobody has a risk factor around me 587(41.0)
Because I prefer alternative therapies (e.g. natural medicine) 511(35.7)
I consider influenza a minor disease 463(32.4)
Because I am afraid of the side effects 451(31.5)
Because of the contradictory opinions on flu vaccine 411(28.7)
I consider the vaccine ineffective 380(26.6)
Because I prefer medical therapy 361(25.2)
Previous bad experience with flu vaccine among family members/acquaintance 341(23.8)
Because I forgot and missed it 263(18.4)
Because I am afraid of the needles 172(12.0)
I received the flu vaccine previously, but it was ineffective because I got the flu 156(10.9)
Influenza vaccine is contraindicated to me 93(6.5)
I received the flu vaccine previously, but I experienced major/serious side effects 85(5.9)
aParticipants’ could give more than one reason
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Factors that motivated or discouraged vaccination uptake
The most frequently cited reasons for having an influ-
enza vaccination were self-protection’ and to pro-
tect those with risk factors around’, which were also
noted in other studies [20, 22, 30], followed by con-
sider flu as a severe disease’. These stated reasons imply
that vaccinated people are more likely to be aware of the
negative impacts of influenza disease. Of note, social re-
sponsibility was an important motivating factor for influ-
enza vaccination. In the unvaccinated group, the most
frequently stated reasons for not having influenza vac-
cination were rarely get influenza’, followed by I do
not have a risk factor’. Surprisingly, we found that par-
ticipants who selected I do not have a risk factor’ in
fact had at least one existing risk factor. It can be as-
sumed that participants’ perception of risk factors needs
to be improved through some type of educational inter-
vention by healthcare professionals. Previous studies
have also shown that the low uptake of the influenza
vaccine is related to the perceived low risk of the disease
[8, 20, 28, 30–32].
More than one-third of vaccinated participants re-
ported that healthcare workers or a family member in-
fluenced their decision to have the influenza vaccine.
Previous studies have also reported that a recommenda-
tion or opinion from healthcare workers or family mem-
bers is a factor that influences whether someone has an
influenza vaccination [8, 20, 30, 33]. Interestingly, some




To have the influenza vaccine
n = 200 (100%)
To not have the influenza vaccine
n = 1431 (100%)





























Not influenced 124(62.0) 888(62.1)
N/A 34(17.0) 104(7.3)
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Number (%) Number (%) Number (%)
Influenza is an infectious disease True Correct 194(97.0) 1333(93.2) 1527(93.6)




NA 2(1.0) 11(0.8) 13(0.8)
Influenza vaccination is recommended annually for the risk groups True Correct 194(97.0) 1122(78.4) 1316(80.7)




NA 3(1.5) 17(1.2) 20(1.2)
Influenza vaccination is highly/specially recommended for the elderly True Correct 189(94.5) 988(69.0) 1282(78.6)




NA 4(2.0) 15(1.1) 21(1.3)
Influenza vaccination is highly/specially recommended for those with chronic
diseases
True Correct 185(92.5) 1093(76.4) 1173(71.9)




NA 2(1.0) 17(1.2) 17(1.0)
Elderly and those with certain chronic diseases can get the flu vaccination for
free
True Correct 183(91.5) 1009(70.5) 1192(73.1)




NA 2(1.0) 14(1.0) 16(1.0)
Influenza is a synonym for common cold False Correct 179(89.5) 1239(86.6) 1418(86.9)




NA 5(2.5) 13(0.9) 18(1.1)
In case of fever the vaccination should be postponed True Correct 177(88.5) 1176(82.2) 1353(83.0)




NA 3(1.5) 15(1.1) 18(1.1)
The best method to prevent influenza is the influenza vaccination True Correct 172(86.0) 619(43.3) 791(48.5)




NA 3(1.5) 20(1.4) 23(1.4)
Time to onset of action is 2 weeks for influenza vaccination in case of adults True Correct 163(81.5) 841(58.8) 1004(61.6)




NA 2(1.0) 21(1.5) 23(1.4)
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of participants stated that they were influenced by
healthcare workers (specialist, GP, pharmacist and other
HCWs) not to take the influenza vaccine; the reason for
this are unclear. It is possible that HCWs may have their
own personal beliefs regarding to influenza and/or
influenza vaccination. A systematic review showed that
HCW’s personal beliefs may act as barriers to vaccine
uptake, including concerns about side effects, scepticism
about vaccine effectiveness and the belief that influenza
is not a serious illness [34].












Number (%) Number (%) Number (%)
Influenza vaccine contains safe ingredients True Correct 159(79.5) 606(42.4) 765(46.9)




NA 2(1.0) 23(1.6) 25(1.5)
Influenza can be prevented by high dose vitamin C (min. 500 mg daily)
instead of vaccination
False Correct 156(78.0) 662(46.3) 818(50.2)




NA 2(1.0) 18(1.3) 20(1.2)
Antibiotics work against influenza False Correct 155(77.5) 953(66.6) 1108(67.9)




NA 3(1.5) 13(0.9) 16(1.0)
The flu vaccination can weaken the immune system False Correct 151(75.5) 652(45.6) 803(49.2)




NA 3(1.5) 20(1.4) 23(1.4)
Influenza can be prevented by herbs (e.g. honey, ginger tea) instead of
vaccination
False Correct 143(71.5) 672(47.0) 815(50.0)




NA 3(1.5) 17(1.2) 20(1.2)
You should not take influenza vaccination if you have already got influenza False Correct 117(58.5) 625(43.7) 742(45.5)




NA 2(1.0) 15(1.0) 17(1.0)
The flu vaccination can cause flu False Correct 109(54.5) 390(27.3) 499(30.6)




NA 2(1.0) 22(1.5) 24(1.5)
In case of egg allergy, the flu vaccination can be taken True Correct 58(29.0) 323(22.6) 381(23.4)




NA 2(1.0) 22(1.5) 24(1.5)
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However, most participants in the present study stated
that their decision was not influenced by any external
source. It can be concluded that most participants’ deci-
sions whether to have the influenza vaccination were
mainly influenced by their own perceptions about influ-
enza disease and/or the influenza vaccine. A previous
systematic review found that perceptions around vaccine
efficacy, safety and adverse events were the most influen-
tial factors in influenza vaccination uptake [27]. Conse-
quently, educational interventions relating to influenza
disease and/or influenza vaccine should be targeted at
patients themselves.
Knowledge about influenza vaccination/influenza disease
This survey found that participants’ level of knowledge
around influenza vaccination and influenza disease asso-
ciated with influenza vaccine uptake. Other studies have
also found a higher level of knowledge to be associated
with higher vaccination uptake rates [21, 27, 29, 35].
Additionally, previous research has shown that a lack of
general knowledge about influenza/influenza vaccination
was a barrier to influenza vaccination uptake [8].
Large differences existed in the level of knowledge be-
tween vaccinated and unvaccinated groups with regard
to assumptions around the best method to prevent
Table 6 Bivariate analysis of general characteristics and participants’ willingness to be vaccinated by a pharmacist
Variable Willingness to be vaccinated by a pharmacist Statistical test p-
valueYes
n = 474 (100%)
No
n = 1157 (100%)
Number (%) Number (%)
Age (years)
(mean ± SD) 32.5 ± 10.8 34.2 ± 10.6 Welch’s two sample t-test 0.0029
Sex













Yes 122(23.8) 390 (76.2) Pearson’s Chi-square test 0.0014
No 352(31.6) 762(68.4)
N/A 0(0.0) 5(100)
Health conditions risk b
Yes 179(28.4) 452(71.6) Pearson’s Chi-square test 0.6238
No 295(29.5) 705 (70.5)
Vaccinated
Yes 116(58.0) 84(42.0) Pearson’s Chi-square test < 0.001
No 358(25.0) 1073(75.0)
Knowledge (n = 1609)
(mean ± SD) 79.3 ± 12.4 69.8 ± 15.5 Welch’s two sample t-test < 0.001
aOccupational risk factors include participants who have at least one of the following statuses: students in the healthcare field; work in health care services; social
institution/long care term facility; nursery school/kindergarten; livestock or animal transfer (swine, poultry, horse); poultry processing or abattoir; work with
immigrants/foreign people
bHealth risk factors include participants who had at least one of following conditions in the previous year: heart failure; coronary artery disease; chronic pulmonary
disease; immune disease; taking immunosuppressive drugs; inflammatory bowel disease; chronic liver disease; chronic kidney disease; pregnancy/planning
pregnancy; disabled (physically); smoker
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influenza, the safety of vaccine ingredients and whether
the influenza vaccine can cause influenza disease. Over-
all, the vaccinated participants were more knowledgeable
than the unvaccinated ones in all other question items.
These findings provide evidence that the lack of know-
ledge regarding the effectiveness and safety of the influ-
enza vaccine in the unvaccinated group might influence
these participants’ attitudes towards influenza
vaccination.
Willingness to accept pharmacists as influenza vaccine
administrators
Previous studies have suggested that pharmacy-provided
vaccines may increase the uptake of the influenza vac-
cine [15, 36, 37]. In Hungary, pharmacy-provided vac-
cines are not yet available. However, this study found
that almost one-third (29.1%) of participants would be
willing to receive their influenza vaccine from pharma-
cists. The participants’ willingness in this regard may in-
dicate that some of them already trust pharmacists to be
vaccine administrators.
The results of the statistical analysis showed significant
differences in the general characteristics of those who, in
principle, said they accepted (the willing group’) and
those who, in principle, said they would refuse (the
unwilling group’) pharmacists as vaccine administra-
tors. Of the demographic factors, sex, occupational risk
factor, level of knowledge and vaccination status were
variables having clinical relevance. These findings imply
that male participants, participants with an occupational
risk factor, participants with a higher level of knowledge
about influenza vaccination/influenza disease and those
who had been vaccinated against influenza were more
willing to be vaccinated by pharmacists.
We observed that the number of participants who
were willing to be vaccinated by pharmacists was two-
times higher than the number of participants who were
actually vaccinated during the 2017/18 influenza season.
These findings suggest that influenza vaccination uptake
in Hungary might be increased if pharmacists were in-
volved. A number of studies into pharmacy-based influ-
enza vaccination services have been published [12, 15,
38]. Studies have reported that patient satisfaction with
pharmacist-administered vaccination was high [39–41].
Being vaccinated by pharmacists would also provide
additional educational opportunities. For example, phar-
macists can deliver correct information about the safety
and quality of the influenza vaccine (e.g. the safety of the
ingredients and quality assurance of the product).
Strengths and limitations
The strength of this study was the large sample size used
to assess influenza vaccine uptake, related knowledge,
and potential role of pharmacist as vaccine
administrators. in Hungary. The findings in this study
are, however, subject to some limitations. Data were
self-reported by participants who were voluntary re-
cruited via Facebook that could induce selection bias and
the reported vaccination rates could not be verified by
checking participants’ medical records (recall bias). Due
to the method, the share of inhabitants below 40 years of
age were overrepresented in the study group which leads
to slight underestimation of influenza vaccination up-
take. Those who are lacking internet access or Facebook
account are not represented in the study group. As so-
cial media access might be associated with level of influ-
enza vaccine acceptance, either directly or indirectly,
this limitation may lead to over- or under-estimation of
influenza vaccination coverage. The study of Ahmed
et al. from the U.S. showed that users of Facebook or
Twitter had higher influenza vaccination uptake, com-
pared to non-users of social media [42]. On the contrary,
a strong anti-vaccine content on Facebook were detected
in some countries [43–45] (note that nowadays Facebook
is reducing the distribution of misinformation about vac-
cination and increasing users’ exposure to credible, au-
thoritative information) [46]. In Hungary, the presence
of anti-vaccine content might only slightly influence the
research findings, since the level of public trust in com-
pulsory vaccinations are above 90% in Hungary and
compulsory childhood vaccine uptake is close to 100%,
which is outstanding in Europe [46].
Based on the survey method, our results may not rep-
resent well the whole Hungarian population. On the
other hand, this exploratory study clearly identified
problematic areas where educational interventions
should focus.
Conclusions
Influenza vaccine uptake among active adults was low in
Hungary. Increased public awareness and improved
knowledge about influenza vaccination and/or influenza
disease is necessary to achieve higher influenza vaccin-
ation uptake rates. Based on the insufficient knowledge
of participants concerning the effectiveness and safety of
the influenza vaccine, combined with the level of accept-
ance among participants to obtain an influenza vaccin-
ation from a pharmacist, we recommend that both the
educational role played by pharmacists should be ex-
tended, while vaccine administrator role should be con-
sidered and implemented.
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